[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
August 1992

PhXA34-Induced Ocular Hypotension

Author Affiliations

Madison, Wis

Arch Ophthalmol. 1992;110(8):1042. doi:10.1001/archopht.1992.01080200022004

To the Editor.  —The article by Alm and Villumsen1 indicated that PhXA34, a congener of prostaglandin F isopropyl ester (PGF-IE), increased tonographic outflow facility in ocular normotensive humans by approximately one third, accounting for approximately one fourth to one third of the drug-induced intraocular pressure (IOP) decrease. The authors state that, because no effect on aqueous flow was found, and assuming that episcleral venous pressure was unchanged, "an increased uveoscleral outflow, as has been demonstrated for PGF-IE in monkeys, is a possible explanation for the remaining pressure reduction." Their use of the word "remaining" implies that the increase in tonographic facility reflected a physiologic process distinct from uveoscleral outflow. Although the authors did not directly so state, most readers would infer from the text that facility of outflow from the anterior chamber into the canal of Schlemm (ie, conventional, trabecular, or true facility) had increased. However, this may well not have

First Page Preview View Large
First page PDF preview
First page PDF preview